These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 20662767)

  • 1. Oestrogen treatment enhances the sensitivity of hormone-resistant breast cancer cells to doxorubicin.
    Scherbakov AM; Lobanova YS; Andreeva OE; Shatskaya VA; Krasil'nikov MA
    Biosci Rep; 2011 Apr; 31(2):137-43. PubMed ID: 20662767
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of TNF-alpha leader sequence renders MCF-7 tumor cells resistant to the cytotoxicity of soluble TNF-alpha.
    Yan D; Qin N; Zhang H; Liu T; Yu M; Jiang X; Feng W; Wang J; Yin B; Zhang T; Zhou M; Li Z
    Breast Cancer Res Treat; 2009 Jul; 116(1):91-102. PubMed ID: 18618239
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sensitization of apoptotically-resistant breast carcinoma cells to TNF and TRAIL by inhibition of p38 mitogen-activated protein kinase signaling.
    Weldon CB; Parker AP; Patten D; Elliott S; Tang Y; Frigo DE; Dugan CM; Coakley EL; Butler NN; Clayton JL; Alam J; Curiel TJ; Beckman BS; Jaffe BM; Burow ME
    Int J Oncol; 2004 Jun; 24(6):1473-80. PubMed ID: 15138590
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel signaling molecules implicated in tumor-associated fatty acid synthase-dependent breast cancer cell proliferation and survival: Role of exogenous dietary fatty acids, p53-p21WAF1/CIP1, ERK1/2 MAPK, p27KIP1, BRCA1, and NF-kappaB.
    Menendez JA; Mehmi I; Atlas E; Colomer R; Lupu R
    Int J Oncol; 2004 Mar; 24(3):591-608. PubMed ID: 14767544
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting of nuclear factor kappaB Pathways by dehydroxymethylepoxyquinomicin, a novel inhibitor of breast carcinomas: antitumor and antiangiogenic potential in vivo.
    Matsumoto G; Namekawa J; Muta M; Nakamura T; Bando H; Tohyama K; Toi M; Umezawa K
    Clin Cancer Res; 2005 Feb; 11(3):1287-93. PubMed ID: 15709200
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of NF-kappaB-mediated transcription and induction of apoptosis in human breast cancer cells by epoxypseudoisoeugenol-2-methyl butyrate.
    Ma G; Tabanca N; Husnu Can Baser K; Kirimer N; Pasco DS; Khan IA; Khan SI
    Cancer Chemother Pharmacol; 2009 Mar; 63(4):673-80. PubMed ID: 18597088
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular mechanisms of loss of beta 2-microglobulin expression in drug-resistant breast cancer sublines and its involvement in drug resistance.
    Ogretmen B; McCauley MD; Safa AR
    Biochemistry; 1998 Aug; 37(33):11679-91. PubMed ID: 9709006
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 1'S-1'-acetoxyeugenol acetate: a novel phenylpropanoid from Alpinia conchigera enhances the apoptotic effects of paclitaxel in MCF-7 cells through NF-κB inactivation.
    In LL; Azmi MN; Ibrahim H; Awang K; Nagoor NH
    Anticancer Drugs; 2011 Jun; 22(5):424-34. PubMed ID: 21346553
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Paradoxical regulation of Bcl-2 family proteins by 17beta-oestradiol in human breast cancer cells MCF-7.
    Leung LK; Wang TT
    Br J Cancer; 1999 Oct; 81(3):387-92. PubMed ID: 10507761
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A P-glycoprotein- and MRP1-independent doxorubicin-resistant variant of the MCF-7 breast cancer cell line with defects in caspase-6, -7, -8, -9 and -10 activation pathways.
    Park SJ; Wu CH; Safa AR
    Anticancer Res; 2004; 24(1):123-31. PubMed ID: 15015586
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Downregulation of NF-kappaB activation in a H4IIE transfectant insensitive to doxorubicin-induced apoptosis.
    Chovolou Y; Wätjen W; Kampkötter A; Kahl R
    Toxicology; 2007 Mar; 232(1-2):89-98. PubMed ID: 17223244
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The breast cancer cells response to chronic hypoxia involves the opposite regulation of NF-kB and estrogen receptor signaling.
    Scherbakov AM; Lobanova YS; Shatskaya VA; Krasil'nikov MA
    Steroids; 2009 Jun; 74(6):535-42. PubMed ID: 19428442
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Mechanism of apoptosis induced by SIRT1 deacetylase inhibitors in human breast cancer MCF-7 drug-resistant cells].
    Li Y; Xu R; Zhang XM; Li DD; He QY
    Yao Xue Xue Bao; 2008 Oct; 43(10):1003-10. PubMed ID: 19127863
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Morphine inhibits doxorubicin-induced reactive oxygen species generation and nuclear factor kappaB transcriptional activation in neuroblastoma SH-SY5Y cells.
    Lin X; Li Q; Wang YJ; Ju YW; Chi ZQ; Wang MW; Liu JG
    Biochem J; 2007 Sep; 406(2):215-21. PubMed ID: 17542780
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting the NF-kappa B pathway in estrogen receptor negative MDA-MB-231 breast cancer cells using small inhibitory RNAs.
    Monks NR; Pardee AB
    J Cell Biochem; 2006 May; 98(1):221-33. PubMed ID: 16408291
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Growth of hormone-dependent MCF-7 breast cancer cells is promoted by constitutive caveolin-1 whose expression is lost in an EGF-R-mediated manner during development of tamoxifen resistance.
    Thomas NB; Hutcheson IR; Campbell L; Gee J; Taylor KM; Nicholson RI; Gumbleton M
    Breast Cancer Res Treat; 2010 Feb; 119(3):575-91. PubMed ID: 19288272
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Over-expression of ERp29 attenuates doxorubicin-induced cell apoptosis through up-regulation of Hsp27 in breast cancer cells.
    Zhang D; Putti TC
    Exp Cell Res; 2010 Dec; 316(20):3522-31. PubMed ID: 20833165
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction of apoptosis in estrogen receptor-negative breast cancer cells by natural and synthetic cyclopentenones: role of the IkappaB kinase/nuclear factor-kappaB pathway.
    Ciucci A; Gianferretti P; Piva R; Guyot T; Snape TJ; Roberts SM; Santoro MG
    Mol Pharmacol; 2006 Nov; 70(5):1812-21. PubMed ID: 16908599
    [TBL] [Abstract][Full Text] [Related]  

  • 19. VP-128, a novel oestradiol-platinum(II) hybrid with selective anti-tumour activity towards hormone-dependent breast cancer cells in vivo.
    Van Themsche C; Parent S; Leblanc V; Descôteaux C; Simard AM; Bérubé G; Asselin E
    Endocr Relat Cancer; 2009 Dec; 16(4):1185-95. PubMed ID: 19661132
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reversal effect of isotetrandrine, an isoquinoline alkaloid extracted from Caulis Mahoniae, on P-glycoprotein-mediated doxorubicin-resistance in human breast cancer (MCF-7/DOX) cells.
    Wang TX; Yang XH
    Yao Xue Xue Bao; 2008 May; 43(5):461-6. PubMed ID: 18717331
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.